NCT07832240

Brief Summary

This pilot feasibility study will evaluate the feasibility and acceptability of delivering Empowered Relief (ER), a single-session pain management intervention, to postpartum patients experiencing severe pain following cesarean delivery during the inpatient period. Participants will be enrolled during their inpatient postpartum hospitalization and randomized 1:1 to receive either ER in addition to standard postpartum care or standard postpartum care alone. Participants will be followed for 12 weeks postpartum.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Oct 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 21, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

October 5, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2027

Last Updated

October 2, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

September 11, 2026

Last Update Submit

September 29, 2026

Conditions

Keywords

Empowered ReliefCesarean DeliveryPostpartum PainAcute Postoperative PainPain ManagementInpatient Postpartum CareCognitive Behavioral Therapy

Outcome Measures

Primary Outcomes (1)

  • Proportion of enrolled participants randomized to the ER intervention who complete the 120-minute ER session during the inpatient postpartum period

    The proportion of participants randomized to the ER intervention arm who complete the 120-minute Empowered Relief (ER) session during the inpatient postpartum period. The proportion will be calculated as the number of participants who complete the ER session divided by the total number of participants randomized to the ER intervention arm.

    Day 1 ± 5 days, during the inpatient postpartum period

Secondary Outcomes (10)

  • Proportion of screened patients who are eligible for the study

    At screening

  • Proportion of eligible patients that consent to study from those approached

    Baseline (Day 1)

  • Proportion of recruited patients randomized to the ER intervention arm who register for the ER session

    Day 1 ± 5 days, during the inpatient postpartum period

  • Proportion of recruited patients randomized to the ER intervention arm who attend the ER session

    Day 1 ± 5 days, during the inpatient postpartum period

  • Treatment Appraisal score (intervention arm)

    Immediately post-intervention or within a defined short window after ER (Day 1 ± 7)

  • +5 more secondary outcomes

Study Arms (2)

Empowered Relief

EXPERIMENTAL

Participants will receive a single 120-minute Empowered Relief session in addition to standard postpartum care. The session includes pain education and cognitive-behavioral pain management skills, including relaxation, deep breathing, reframing, and development of a personalized plan. Participants will also receive access to a smartphone relaxation resource (Calm Tool app, or a relaxation audio file if the app cannot be downloaded).

Behavioral: Empowered Relief

Standard Postpartum Care

NO INTERVENTION

Participants randomized to the control group will receive standard postpartum care alone.

Interventions

A single 120-minute pain relief skills class delivered by trained, certified instructors via Zoom or in person. The session includes pain education, cognitive behavioral skills including relaxation, deep breathing, and reframing, and completion of a personalized plan. Following the session, participants receive access to the Calm Tool smartphone relaxation app (or a binaural relaxation audio file if the app cannot be downloaded).

Empowered Relief

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Complete informed consent.
  • Age 18 years or above.
  • Postpartum woman who delivered by cesarean within the Stanford Healthcare system.
  • Viable birth (singleton or multiple gestation).
  • All maternal demographics and complications are eligible: parity, medical conditions (e.g., pre-eclampsia, gestational diabetes), and post-surgical complications (e.g., hysterectomy, ICU admission, extended hospital stay), provided the participant is clinically able to complete the study intervention and procedures.
  • Currently hospitalized during the postpartum period following cesarean delivery.
  • Severe pain, defined as at least 2 pain scores \>6/10 on the numeric rating scale (NRS), following cesarean delivery.
  • English fluency, with ability to read and write.
  • Ability to adhere to and complete study procedures.
  • Access to a smart device if attending ER session via Zoom.

You may not qualify if:

  • Age under 18 years.
  • Medical or clinical instability that, in the judgment of the treating or research team, would preclude safe participation in the study procedures and/or intervention.
  • Chronic pain prior to pregnancy.
  • Cognitive impairment or psychological factors that would preclude comprehension of study material or full participation.
  • Unable or unwilling to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lucile Packard Children's Hospital Stanford

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

PainChronic PainPain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Central Study Contacts

Guillermina Ferrea, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Because the behavioral intervention cannot be masked, the study is open-label. All outcomes are participant-reported.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized 1:1 to either Empowered Relief plus standard postpartum care or standard postpartum care alone.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology, Perioperative and Pain Medicine (Obstetrics)

Study Record Dates

First Submitted

September 11, 2026

First Posted

September 21, 2026

Study Start (Estimated)

October 5, 2026

Primary Completion (Estimated)

January 15, 2027

Study Completion (Estimated)

April 9, 2027

Last Updated

October 2, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations